Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
33.510
Open
32.900
VWAP
32.48
Vol
307.36K
Mkt Cap
1.19B
Low
31.880
Amount
9.98M
EV/EBITDA(TTM)
6.81
Total Shares
36.33M
EV
2.53B
EV/OCF(TTM)
19.68
P/S(TTM)
0.85
Ingevity Corporation is engaged in developing, marketing, and bringing to market solutions that are renewably sourced. The Company operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. Performance Materials segment engineers, manufactures, and sells hardwood-based, chemically activated carbon products, which are produced through a technical and specialized process primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Performance Chemicals segment is comprised of two product lines: road technologies and industrial specialties. Its products are utilized in pavement construction, preservation, reconstruction and recycling, agrochemical dispersants, paper chemicals and other diverse industrial uses. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
FY2025Q1
379.67M
+0.73%
1.415
+28.64%
385.40M
-1.33%
1.295
+28.22%
285.47M
-16.06%
0.738
+41.83%
Estimates Revision
The market is revising Downward the revenue expectations for Ingevity Corporation (NGVT) for FY2025, with the revenue forecasts being adjusted by -3.61% over the past three months. During the same period, the stock price has changed by -28.76%.
Revenue Estimates for FY2025
Revise Downward
-3.61%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+3.1%
In Past 3 Month
Stock Price
Go Down
-28.76%
In Past 3 Month
3 Analyst Rating
36.32% Upside
Wall Street analysts forecast NGVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NGVT is 44.33 USD with a low forecast of 32.00 USD and a high forecast of 51.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy
36.32% Upside
Current: 32.520
Low
32.00
Averages
44.33
High
51.00
36.32% Upside
Current: 32.520
Low
32.00
Averages
44.33
High
51.00
Wells Fargo
Michael Sison
Hold
Maintains
$45 → $32
2025-04-09
Reason
Wells Fargo
Michael Sison
Price Target
$45 → $32
2025-04-09
Maintains
Hold
Reason
Wells Fargo lowered the firm's price target on Ingevity to $32 from $45 and keeps an Equal Weight rating on the shares. Given increased risks in a post tariff world, the firm recommends a more defensive position within the chemicals sector into Q1 2025 results as Wells expects cautious outlook commentary.
BMO Capital
John McNulty
Hold
to
Buy
Upgrades
$62 → $65
2025-02-26
Reason
BMO Capital
John McNulty
Price Target
$62 → $65
2025-02-26
Upgrades
Hold
to
Buy
Reason
BMO Capital analyst John McNulty raised the firm's price target on Ingevity to $62 from $61 and keeps a Market Perform rating on the shares after its Q4 earnings beat. The company is starting to reap the benefits of roughly two years of work to escape the pressures of its CTO - Crude Tall Oil - platform, the analyst tells investors in a research note. Ingevity is also seeing its high value add Performance Materials business enjoying growth despite muted end-market volumes, BMO adds.
BMO Capital
John McNulty
Hold
Maintains
$61 → $62
2025-02-20
Reason
BMO Capital
John McNulty
Price Target
$61 → $62
2025-02-20
Maintains
Hold
Reason
BMO Capital analyst John McNulty raised the firm's price target on Ingevity to $62 from $61 and keeps a Market Perform rating on the shares after its Q4 earnings beat. The company is starting to reap the benefits of roughly two years of work to escape the pressures of its CTO - Crude Tall Oil - platform, the analyst tells investors in a research note. Ingevity is also seeing its high value add Performance Materials business enjoying growth despite muted end-market volumes, BMO adds.
BMO Capital
John McNulty
Hold
Maintains
$40 → $47
2024-10-31
Reason
BMO Capital
John McNulty
Price Target
$40 → $47
2024-10-31
Maintains
Hold
Reason
BMO Capital
John McNulty
Hold
Maintains
$42 → $40
2024-09-30
Reason
BMO Capital
John McNulty
Price Target
$42 → $40
2024-09-30
Maintains
Hold
Reason
BMO Capital lowered the firm's price target on Ingevity to $40 from $42 and keeps a Market Perform rating on the shares as part of a broader research note on U.S. Chemicals. The firm's channel checks point to a handful of end-markets and commodities that enjoyed relative strength, while at the same time there were pockets of incremental weakness, particularly in Europe and China, the analyst tells investors in a research note. For the company, BMO is lowering its Performance Chemicals segment outlook for the second half of the year as weather has been an issue for Ingevity so far this summer, which impacts the paving business.
BMO Capital
John McNulty
Hold
Maintains
$45 → $42
2024-08-05
Reason
BMO Capital
John McNulty
Price Target
$45 → $42
2024-08-05
Maintains
Hold
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Ingevity Corp (NGVT.N) is 7.46, compared to its 5-year average forward P/E of 13.46. For a more detailed relative valuation and DCF analysis to assess Ingevity Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
13.46
Current PE
7.46
Overvalued PE
16.67
Undervalued PE
10.25
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Strongly Undervalued
5Y Average EV/EBITDA
8.83
Current EV/EBITDA
6.43
Overvalued EV/EBITDA
10.01
Undervalued EV/EBITDA
7.66
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
1.58
Current PS
0.88
Overvalued PS
2.06
Undervalued PS
1.09
Financials
Annual
Quarterly
FY2024Q4
YoY :
-19.61%
298.80M
Total Revenue
FY2024Q4
YoY :
+431.13%
56.30M
Operating Profit
FY2024Q4
YoY :
-114.21%
16.60M
Net Income after Tax
FY2024Q4
YoY :
-114.29%
0.46
EPS - Diluted
FY2024Q4
YoY :
+157.14%
39.60M
Free Cash Flow
FY2024Q4
YoY :
+112.99%
34.10
Gross Profit Margin - %
FY2024Q4
YoY :
-35.52%
3.63
FCF Margin - %
FY2024Q4
YoY :
-117.70%
5.56
Net Margin - %
FY2024Q4
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
14.0K
Volume
2
Bought
0-3
0
0.0
Volume
Months
3-6
1
429.8K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
NGVT News & Events
Events Timeline
2025-03-10 (ET)
2025-03-10
16:17:25
Ingevity names David Li president, CEO
2025-02-18 (ET)
2025-02-18
16:17:54
Ingevity sees FY25 revenue $1.3B-$1.4B, consensus $1.45B
2025-01-16 (ET)
2025-01-16
05:37:17
Ingevity to explore strategic alternatives for Performance Chemicals line
Sign Up For More Events
Sign Up For More Events
News
9.5
04-24NewsfilterIngevity announces dates for first-quarter 2025 earnings release and webcast
7.0
04-01NASDAQ.COMLobbying Update: $80,000 of INGEVITY CORPORATION lobbying was just disclosed
7.0
04-01NASDAQ.COMLobbying Update: $30,000 of INGEVITY CORPORATION lobbying was just disclosed
Sign Up For More News
People Also Watch
CASS
Cass Information Systems Inc
41.070
USD
+1.23%
EBF
Ennis Inc
17.840
USD
-0.45%
HUMA
Humacyte Inc
1.460
USD
+1.39%
QD
Qudian Inc
2.730
USD
+3.02%
TREE
Lendingtree Inc
52.110
USD
+1.11%
KULR
KULR Technology Group Inc
1.370
USD
+1.48%
AMBC
Ambac Financial Group Inc
8.030
USD
+0.50%
CMTG
Claros Mortgage Trust Inc
2.430
USD
0.00%
TMCI
Treace Medical Concepts Inc
6.900
USD
+2.68%
OMER
Omeros Corp
7.270
USD
-0.55%
FAQ
What is Ingevity Corp (NGVT) stock price today?
The current price of NGVT is 32.52 USD — it has decreased -1.09 % in the last trading day.
What is Ingevity Corp (NGVT)'s business?
What is the price predicton of NGVT Stock?
What is Ingevity Corp (NGVT)'s revenue for the last quarter?
What is Ingevity Corp (NGVT)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Ingevity Corp (NGVT)'s fundamentals?
How many employees does Ingevity Corp (NGVT). have?